• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PAJUNK GMBH MEDIZIINTECHNOLOGIE SPROTTE NRFIT; SPINAL NEEDLE, SINGLE USE, PRODUCT CODE: BSP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PAJUNK GMBH MEDIZIINTECHNOLOGIE SPROTTE NRFIT; SPINAL NEEDLE, SINGLE USE, PRODUCT CODE: BSP Back to Search Results
Model Number 021163-29A
Device Problem Device Handling Problem (3265)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/28/2023
Event Type  malfunction  
Event Description
Irn# (b)(4).Subject was brought to sedation unit for ip/sham procedure.Pharmacy provided sponsor's nrfit needles to be used per protocol for this procedure, which were different than those used on the previous study patient for the same procedure.Site was identified by palpation and sterilized.The patient was sedated and first attempt at csf collection was performed after sedation was assured.Upon first attempt using the provided nrfit lp 22 g needle, the provider was unable to access the intrathecal space due to the introducer length and inflexibility.The second attempt was made using the 25 g nrfit needle set and again, provider was unable to access the intrathecal space using this spinal needle set.Blood was returning and the concern was that repeated attempts with nrfit needles would result in potential for epidural hematoma.There were concerns that the nrfit needles would not appropriately access the intrathecal space.The procedure was continued with commercial/standard lp needle 22g x 1.5 in.The intrathecal space was accessed easily with standard needle and 3 cc of csf was collected for processing.Oav101b12301 ip was prepped to connect to the needle set for injection but it was found that the connector was not compatible with the hub of the standard commercial spinal needle.In order for procedure to continue, nrfit introducer was connected into the hub of the standard lp needle to push medication through the two needles and into the intrathecal space.In doing so, approximately 0.5 - 1 ml of fluid (csf and/or study drug) leaked out of the hub of the spinal needle and the rest entered the intrathecal space appropriately.The patient was cleaned, sedation lifted and the rest of study protocol completed.No adverse event was associated with the procedure.
 
Manufacturer Narrative
Currently the available data is poor.Investigation is still running.As soon as further information becomes available a follow up report will be sent in to the agency.
 
Manufacturer Narrative
Event took place in usa.Based on analysis, risk assessment, risk profile and clinical monitoring this file is considered as closed.In case new information becomes available a follow up report will be sent to the agency.Supplement: the initial report ran via cfn-based-no.9611612-2023-00003.In comparison to the initial report, data corrections were made in this final report due to new findings.Based on risk assessment and clinical assessment this file is considered as closed.Follow up / final report has been delayed due to technical problems.
 
Event Description
Irn# (b)(4).Subject was brought to sedation unit for ip/sham procedure.Pharmacy provided sponsor's nrfit needles to be used per protocol for this procedure, which were different than those used on the previous study patient for the same procedure.Site was identified by palpation and sterilized.The patient was sedated and first attempt at csf collection was performed after sedation was assured.Upon first attempt using the provided nrfit lp 22 g needle, the provider was unable to access the intrathecal space due to the introducer length and inflexibility.The second attempt was made using the 25 g nrfit needle set and again, provider was unable to access the intrathecal space using this spinal needle set.Blood was returning and the concern was that repeated attempts with nrfit needles would result in potential for epidural hematoma.There were concerns that the nrfit needles would not appropriately access the intrathecal space.The procedure was continued with commercial/standard lp needle 22g x 1.5 in.The intrathecal space was accessed easily with standard needle and 3 cc of csf was collected for processing.(b)(4) was prepped to connect to the needle set for injection but it was found that the connector was not compatible with the hub of the standard commercial spinal needle.In order for procedure to continue, nrfit introducer was connected into the hub of the standard lp needle to push medication through the two needles and into the intrathecal space.In doing so, approximately 0.5 - 1 ml of fluid (csf and/or study drug) leaked out of the hub of the spinal needle and the rest entered the intrathecal space appropriately.The patient was cleaned, sedation lifted and the rest of study protocol completed.No adverse event was associated with the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPROTTE NRFIT
Type of Device
SPINAL NEEDLE, SINGLE USE, PRODUCT CODE: BSP
Manufacturer (Section D)
PAJUNK GMBH MEDIZIINTECHNOLOGIE
karl-hall-str. 1
tuttlinger str.7
geisingen 78187
Manufacturer (Section G)
PAJUNK GMBH MEDIZINTECHNOLOGIE
karl-hall str. 1
tuttlinger str. 7
geisingen 78187
Manufacturer Contact
christian quass
karl-hall-str. 1
tuttlinger str. 7
geisingen 78187
0499291586
MDR Report Key16866123
MDR Text Key314536558
Report Number9611612-2023-00003
Device Sequence Number1
Product Code BSP
UDI-Device Identifier04048223114803
UDI-Public04048223114803
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160295
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 12/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/04/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number021163-29A
Device Catalogue Number021163-29A
Device Lot Number1457
Was Device Available for Evaluation? No
Date Manufacturer Received05/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/13/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-